![Akebia Therapeutics gets complete response letter from the FDA for vadadustat for CKD-associated anemia - Drug Discovery and Development Akebia Therapeutics gets complete response letter from the FDA for vadadustat for CKD-associated anemia - Drug Discovery and Development](https://www.drugdiscoverytrends.com/wp-content/uploads/2022/03/Akebia_Otsuka.gif)
Akebia Therapeutics gets complete response letter from the FDA for vadadustat for CKD-associated anemia - Drug Discovery and Development
![FDA to review Akebia's and Otsuka's vadadustat for anemia resulting from chronic kidney disease - Drug Discovery and Development FDA to review Akebia's and Otsuka's vadadustat for anemia resulting from chronic kidney disease - Drug Discovery and Development](https://www.drugdiscoverytrends.com/wp-content/uploads/2023/03/pfizer-emory-268x170.png)
FDA to review Akebia's and Otsuka's vadadustat for anemia resulting from chronic kidney disease - Drug Discovery and Development
![Vifor Pharma, Akebia Strike Licensing Deal for Anemia Drug Vadadustat - Drug Discovery and Development Vifor Pharma, Akebia Strike Licensing Deal for Anemia Drug Vadadustat - Drug Discovery and Development](https://drugdiscoverytrends.com/wp-content/uploads/2019/10/ddd1705_pills_stock.jpg)